MedPath

Phentolamine Mesylate

Phentolamine Mesylate for Injection USP, 5mg

Approved
Approval ID

fe1e10f5-4ff3-4616-9534-489648d88d33

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 17, 2021

Manufacturers
FDA

TAGI Pharma, Inc.

DUNS: 963322560

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Phentolamine Mesylate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51224-012
Application NumberANDA207686
Product Classification
M
Marketing Category
C73584
G
Generic Name
Phentolamine Mesylate
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateDecember 17, 2021
FDA Product Classification

INGREDIENTS (3)

Natural Latex RubberInactive
Quantity: 0 1 in 1 1
Code: 2LQ0UUW8IN
Classification: CNTM
MannitolInactive
Quantity: 25 mg in 1 1
Code: 3OWL53L36A
Classification: IACT
Phentolamine MesylateActive
Quantity: 5 mg in 1 1
Code: Y7543E5K9T
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.